Ezose Sciences, Inc. in New Agreement with Merck & Co., Inc. to Advance Glycan Biomarker Discovery in Diabetes
PINE BROOK, N.J.--(BUSINESS WIRE)--Ezose Sciences Inc. announced today that it has entered an agreement with Merck, through a subsidiary, to collaborate on biomarker discovery research in the field of diabetes. The collaboration seeks to identify glycans, the complex carbohydrate component of glycoproteins, which can play a role in health and disease.